Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch

Journal of Addictive Diseases

Volumn 32, Issue 1, 2013, Pages 46-52

  Schnoll, Robert A ^a   Leone, Frank T ^b   Hitsman, Brian ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CESD; depression; Smoking cessation; withdrawal

Indexed keywords

NICOTINE; NICOTINE PATCH;

ADULT; ARTICLE; BEHAVIOR; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSION; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGY; SMOKING; SMOKING CESSATION; SYMPTOM; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AFFECT; ANHEDONIA; DEPRESSION; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; NICOTINE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875355527     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2012.759870     Document Type: Article

References (36)

1. Ameringer KJ, Leventhal AM. Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review. Nicotine Tob Res 2010; 12:1183-94.
2. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997; 154:263-5. (Pubitemid 27053736)
3. Hitsman B, Borrelli B, McChargue DE, Spring B, Niaura R. History of depression and smoking cessation outcome: a metaanalysis. J Consult Clin Psychology 2003; 71:657-63. (Pubitemid 36897398)
4. Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychology 2003; 71:292-301. (Pubitemid 36323933)
5. Hitsman B, Pingitore R, Spring B, et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychology 1999; 67:547-54. (Pubitemid 29379468)
6. Kinnunen T, Doherty K, Militello FS, Garvey AJ. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Consult Clinical Psychology 1996; 64:791-8. (Pubitemid 26274542)
7. Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychology Addict Beh 2001; 15:13-7. (Pubitemid 32194935)
8. Schnoll RA, Martinez E, Tatum K, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Cont 2010; 21:811-20.
9. Swan GE, Jack LM, ChorostM, et al. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nic Tob Res, 2003; 5:911-21. (Pubitemid 38029087)
10. Pomerleau CS, Marks JL, Pomerleau OF. Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nic Tob Res 2000; 2:275-80.
11. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nic Tob Res 2005; 7:91-102. (Pubitemid 40613166)
12. Pomerleau OF, Pomerleau CS, Snedecor SM, Gaulrapp S, Brouwer RN, Cameron OG. Depression, smoking abstinence and HPA function in women smokers. Hum Psychopharm Clin Exp 2004; 19:467-76. (Pubitemid 39378269)
13. Wileyto P, O'Loughlin J, Lagerlund M, Meshefedjian G, Dugas E, Gervais A. Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers. Tob Cont 2009; 18:387-92.
14. Leventhal AM, Ramsey S., Brown RA, LaChance HR, Kahler CW. Dimensions of depressive symptoms and smoking cessation. Nic Tob Res 2008; 10:507-17. (Pubitemid 351385832)
15. Pomerleau CS, Zucker AN, Stewart AJ. Patterns of depressive symptomatology in women smokers, ex-smokers, and neversmokers. Addict Behav 2003; 28:575-82. (Pubitemid 36287297)
16. Devins GM, Orme CM, Costello CG, Binik, YM. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Heal 1988; 2:139-56.
17. Knight RG, Williams S, McGee R, Olaman S. Psychometric properties of the Centre for Epidemiologic Studies Depression Scale (CES-D) in a sample of women in middle life. Beh Res Ther 1997; 35: 373-80. (Pubitemid 27139912)
18. Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006; 62:123-146.
19. Schnoll RA, Wileyto P, Leone FT, Tyndale RF, Benowitz NL. High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial. Nic Tob Res 2013; 15:348-54.
20. Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Internal Med 1999; 140:426-33.
21. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nic Tob Res 2003; 5: 13-25. (Pubitemid 36285465)
22. Dempsey D, Tutka P, Jacob P 3rd, Allen F, Schoedel K, et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004; 76:64-72. (Pubitemid 38844735)
23. Lerman C, Tyndale R, Patterson F, et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Thera 2006; 79: 600-8. (Pubitemid 43817942)
24. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Clin Pharmacol Ther 2009; 92:6-11.
25. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD- 10. J Clin Psychiatry 1998; 59:22-33. (Pubitemid 29001829)
26. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119-27.
27. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacol (Berl) 1984; 83: 82-7. (Pubitemid 14141493)
28. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. NicTob Res 2001; 3: 7-16. (Pubitemid 32611534)
29. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 1063-70.
30. Radloff L. The CES-D scale: A new selfreport depression scale for research in the general population. App Psychol Measure 1977; 1:385-401.
31. Blazer DG, Hybels CF. What symptoms of depression predictmortality in communitydwelling elders? J Amer Geriatrics Soc 2004; 52:2052-6. (Pubitemid 41725022)
32. Benowitz NL, Jacob P, Ahijevych K, Jarvis MJ, Hall S, LeHouezec J. Biochemical verification of tobacco use and cessation. Nic Tob Res 2002; 4:149-59. (Pubitemid 34679841)
33. Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pre-treatment depressive symptoms in smoking cessation: twelve month results of a randomized placebo controlled trial. Inter J Psychiatry Med 2008; 38:373-89.
34. Catley D, Ahluwalia JS, Resnicow K, Nazir N. Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch. NicTob Res, 2003; 5:61-8. (Pubitemid 36285468)
35. Malpass D, Higgs S. Acute psychomotor, subjective, and physiological responses to smoking in depressed outpatient smokers and matched controls. Psychopharmacol 2007; 190:363-72. (Pubitemid 46155645)
36. Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addict 2011; 106:418-27.